Education
About Us
Working with TipRanks
Follow Us
TG Therapeutics (TGTX)
NASDAQ:TGTX
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 329.00M | $ 233.66M | $ 2.79M | $ 6.69M | $ 152.00K |
| Gross Profit | $ 290.52M | $ 219.11M | $ 2.52M | $ 5.90M | $ -222.00K |
| Operating Income | $ 41.93M | $ 20.63M | $ -192.84M | $ -344.77M | $ -273.59M |
| EBITDA | $ 49.90M | $ 26.10M | $ -187.63M | $ -341.97M | $ -272.68M |
| Net Income | $ 23.38M | $ 12.67M | $ -203.83M | $ -355.55M | $ -285.88M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 311.00M | $ 217.51M | $ 174.08M | $ 350.30M | $ 605.43M |
| Total Assets | $ 577.69M | $ 329.59M | $ 193.57M | $ 379.63M | $ 625.64M |
| Total Debt | $ 253.72M | $ 110.80M | $ 83.06M | $ 79.05M | $ 41.98M |
| Net Debt | $ 73.83M | $ 17.86M | $ -19.24M | $ -219.84M | $ -511.46M |
| Total Liabilities | $ 355.33M | $ 169.09M | $ 134.99M | $ 142.48M | $ 106.29M |
| Stockholders' Equity | $ 222.36M | $ 160.50M | $ -1.53B | $ -1.33B | $ 519.35M |
| Cash Flow | |||||
| Free Cash Flow | $ -40.52M | $ -31.41M | $ -176.18M | $ -296.04M | $ -214.86M |
| Operating Cash Flow | $ -40.52M | $ -31.41M | $ -176.17M | $ -295.63M | $ -214.51M |
| Investing Cash Flow | $ -1.04M | $ -50.65M | $ -20.01M | $ -332.00K | $ -24.51M |
| Financing Cash Flow | $ 128.53M | $ 72.70M | $ -391.00K | $ 41.42M | $ 679.83M |